Article thumbnail

Assessment of the Risk/Benefit Ratio of Phase II Cancer Clinical Trials by Institutional Review Board (IRB) members

By A.W. Musschenga, R.B. Keus, W.M. Robinson and N.K. Aaronson
Year: 2003
DOI identifier: 10.1093/annonc/mdf209
OAI identifier:
Provided by: DSpace at VU
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.